LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Eledon Pharmaceuticals, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERELDN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ELDN COVERAGE

What’s moving Eledon Pharmaceuticals, Inc. now

Current reporting with the operating signal separated from the noise.

01
Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.

The story matters when it changes Eledon Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Eledon Pharmaceuticals, Inc. (ELDN) is a Great Momentum Stock: Should You Buy?

Eledon Pharmaceuticals, Inc. (ELDN) is a Great Momentum Stock: Should You Buy?

Investors are testing whether Eledon Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q1 2023 Earnings Call Transcript

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q1 2023 Earnings Call Transcript

Investors are testing whether Eledon Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Earnings Call Transcript

Eledon Pharmaceuticals, Inc. (ELDN) CEO David-Alexandre Gros on Q3 2021 Results

The story matters when it changes Eledon Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Eledon Pharmaceuticals, Inc. (ELDN) Fell Out Of Favor With Hedge Funds

Eledon Pharmaceuticals, Inc. (ELDN) Fell Out Of Favor With Hedge Funds

The story matters when it changes Eledon Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ELDN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-19 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-22 · Period 2026-06-18SEC ↗8-KMaterial company eventFiled 2026-05-13 · Period 2026-05-13SEC ↗8-KMaterial company eventFiled 2026-03-19 · Period 2026-03-19SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-30 · Period 2026-06-18SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Eledon Pharmaceuticals, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.